MARLBOROUGH, Mass.--(BUSINESS WIRE)--Optos plc (LSE: OPTS), a world leader in retinal imaging, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) ...

Please provide your email address to receive an email when new articles are posted on . An OCT integrated into an ultra-widefield device provides similar visualization of retinal structural details in ...

Optos and Zeiss explain how technology is supporting early detection in practice, and one Leicestershire optometrist shares ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Please provide your email address to receive an email when new articles are posted on . Optos plc, part of Nikon Corp., announced the U.S. launch of Monaco, the first ultra-widefield imaging device ...

EYE scanning machine maker Optos is on course to launch “the most important device in its history” in America in October after yesterday receiving the nod from US regulators. The “Daytona” machine, ...

Optos says deal for $17.5 mln Deal to close in Q4 Optos enters $30 mln credit pact Sept 22 (Reuters) - Scottish retinal-imaging equipment firm Optos offered to buy a unit of U.S.-based Opko Health Inc ...